Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

REFOCUS-HTN US-WEST: a Data Infrastructure to Characterize Contemporary Individuals With Hypertension, Their Care, Health Outcomes, and Wellbeing

NCT07780500 is registered in ClinicalTrials.gov with Kaiser Permanente as lead sponsor.

NCT NCT07780500
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07780500 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
REFOCUS-HTN US-WEST: a Data Infrastructure to Characterize Contemporary Individuals With Hypertension, Their Care, Health Outcomes, and Wellbeing
Lead sponsor
Kaiser Permanente
Phase
Observational
Overall status
Recruiting
Start date
August 20, 2026
Completion date
March 31, 2029
Enrollment
500 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

aldosterone disorder, cardiovascular disease (cvd), hypertension